Cargando…
Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies
The objective of this study was to develop a novel implant containing risperidone intended for long-term treatment in Schizophrenia utilizing in vitro in vivo correlation (IVIVC) studies. Different implants (F1-F8) containing an antipsychotic drug, risperidone, were prepared using a hot melt extrusi...
Autores principales: | Navitha, Aerrolla, Jogala, Satheesh, Krishnamohan, Chinnala, Aukunuru, Jithan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065469/ https://www.ncbi.nlm.nih.gov/pubmed/24959417 http://dx.doi.org/10.4103/2231-4040.133431 |
Ejemplares similares
-
Development of a novel 3-month drug releasing risperidone microspheres
por: Yerragunta, Bhanusree, et al.
Publicado: (2015) -
Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin
por: Jogala, Satheesh, et al.
Publicado: (2015) -
Preparation and evaluation of a novel oral delivery system for low molecular weight heparin
por: Lavanya, Nallaguntla, et al.
Publicado: (2016) -
Development and evaluation of a novel biodegradable sustained release microsphere formulation of paclitaxel intended to treat breast cancer
por: Shiny, Jacob, et al.
Publicado: (2013) -
Preparation and Characterization of PEG-albumin-curcumin Nanoparticles Intended to Treat Breast Cancer
por: Thadakapally, R., et al.
Publicado: (2016)